205 related articles for article (PubMed ID: 22006831)
61. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
62. Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production.
Liao HW; Huang TH; Chang YH; Liou HH; Chou YH; Sue YM; Hung PH; Chang YT; Ho PC; Tsai KJ
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027235
[TBL] [Abstract][Full Text] [Related]
63. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.
Maïmoun L; Couret I; Mariano-Goulart D; Dupuy AM; Micallef JP; Peruchon E; Ohanna F; Cristol JP; Rossi M; Leroux JL
Calcif Tissue Int; 2005 Jun; 76(6):404-11. PubMed ID: 15812577
[TBL] [Abstract][Full Text] [Related]
64. Patients with non-ambulatory cerebral palsy have higher sclerostin levels and lower bone mineral density than patients with ambulatory cerebral palsy.
Shin YK; Yoon YK; Chung KB; Rhee Y; Cho SR
Bone; 2017 Oct; 103():302-307. PubMed ID: 28720522
[TBL] [Abstract][Full Text] [Related]
65. From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD.
Brandenburg VM; D'Haese P; Deck A; Mekahli D; Meijers B; Neven E; Evenepoel P
Pediatr Nephrol; 2016 Feb; 31(2):195-206. PubMed ID: 25735207
[TBL] [Abstract][Full Text] [Related]
66. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
67. Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone.
Idolazzi L; Fassio A; Tripi G; Braga V; Viapiana O; Adami G; Rossini M; Gatti D
Clin Rheumatol; 2017 Apr; 36(4):925-928. PubMed ID: 28054306
[TBL] [Abstract][Full Text] [Related]
68. Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury.
Gifre L; Vidal J; Carrasco JL; Muxi A; Portell E; Monegal A; Guañabens N; Peris P
Osteoporos Int; 2016 Jan; 27(1):405-10. PubMed ID: 26423406
[TBL] [Abstract][Full Text] [Related]
69. Bone fragility after spinal cord injury: reductions in stiffness and bone mineral at the distal femur and proximal tibia as a function of time.
Haider IT; Lobos SM; Simonian N; Schnitzer TJ; Edwards WB
Osteoporos Int; 2018 Dec; 29(12):2703-2715. PubMed ID: 30334093
[TBL] [Abstract][Full Text] [Related]
70. Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.
Piemonte S; Romagnoli E; Bratengeier C; Woloszczuk W; Tancredi A; Pepe J; Cipriani C; Minisola S
J Endocrinol Invest; 2012 Oct; 35(9):866-8. PubMed ID: 22842667
[TBL] [Abstract][Full Text] [Related]
71. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
[TBL] [Abstract][Full Text] [Related]
72. Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.
van Lierop AH; van der Eerden AW; Hamdy NA; Hermus AR; den Heijer M; Papapoulos SE
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1953-7. PubMed ID: 22844062
[TBL] [Abstract][Full Text] [Related]
73. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
Yamamoto M; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
[TBL] [Abstract][Full Text] [Related]
74. Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women.
Urano T; Shiraki M; Ouchi Y; Inoue S
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1473-7. PubMed ID: 22639287
[TBL] [Abstract][Full Text] [Related]
75. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
Drake MT; Srinivasan B; Mödder UI; Peterson JM; McCready LK; Riggs BL; Dwyer D; Stolina M; Kostenuik P; Khosla S
J Clin Endocrinol Metab; 2010 Nov; 95(11):5056-62. PubMed ID: 20631014
[TBL] [Abstract][Full Text] [Related]
76. Circulating sclerostin in children and young adults with heritable bone disorders.
Palomo T; Glorieux FH; Rauch F
J Clin Endocrinol Metab; 2014 May; 99(5):E920-5. PubMed ID: 24512494
[TBL] [Abstract][Full Text] [Related]
77. Negative Association Between Sclerostin and INSL3 in Isolated Human Osteocytes and in Klinefelter Syndrome: New Hints for Testis-Bone Crosstalk.
Di Nisio A; De Toni L; Rocca MS; Ghezzi M; Selice R; Taglialavoro G; Ferlin A; Foresta C
J Clin Endocrinol Metab; 2018 May; 103(5):2033-2041. PubMed ID: 29452406
[TBL] [Abstract][Full Text] [Related]
78. Regulation of circulating sclerostin levels by sex steroids in women and in men.
Mödder UI; Clowes JA; Hoey K; Peterson JM; McCready L; Oursler MJ; Riggs BL; Khosla S
J Bone Miner Res; 2011 Jan; 26(1):27-34. PubMed ID: 20499362
[TBL] [Abstract][Full Text] [Related]
79. Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.
Erlandson KM; O'Riordan M; Hileman CO; Rapaport E; Labbato D; Campbell TB; McComsey GA
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):731-8. PubMed ID: 25919636
[TBL] [Abstract][Full Text] [Related]
80. Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography.
Frey-Rindova P; de Bruin ED; Stüssi E; Dambacher MA; Dietz V
Spinal Cord; 2000 Jan; 38(1):26-32. PubMed ID: 10762194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
